MENU
COR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

COR stock forecast, quote, news & analysis

Cencora is one of three leading domestic pharmaceutical wholesalers... Show more

COR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for COR with price predictions
Sep 16, 2026

COR sees MACD Histogram just turned negative

COR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 09, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 52 instances where the indicator turned negative. In 27 of the 52 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 52%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for COR moved out of overbought territory on August 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 21 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COR as a result. In 33 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.

COR broke above its upper Bollinger Band on September 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where COR advanced for three days, in 239 of 386 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 225 of 348 cases where COR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 27 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. COR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: COR's P/B Ratio (19.920) is slightly higher than the industry average of (7.612). P/E Ratio (23.645) is within average values for comparable stocks, (19.276). COR's Projected Growth (PEG Ratio) (0.667) is slightly lower than the industry average of (1.309). Dividend Yield (0.007) settles around the average of (0.007) among similar stocks. P/S Ratio (0.187) is also within normal values, averaging (3.882).

A.I.Advisor
published Dividends

COR paid dividends on August 31, 2026

Cencora COR Stock Dividends
А dividend of $0.60 per share was paid with a record date of August 31, 2026, and an ex-dividend date of August 14, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 20.81B. The market cap for tickers in the group ranges from 557.05K to 103.45B. MCK holds the highest valuation in this group at 103.45B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was -0%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -28%. COSM experienced the highest price growth at 17%, while SNYR experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 4,873%. For the same stocks of the Industry, the average monthly volume growth was 524% and the average quarterly volume growth was 3,294%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 60
Price Growth Rating: 64
SMR Rating: 88
Profit Risk Rating: 74
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
COR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry MedicalDistributors

Profile
Details
Industry
Real Estate Investment Trusts
Address
1 West First Avenue
Phone
+1 610 727-7000
Employees
51000
Web
https://www.cencora.com
COR sees MACD Histogram just turned negative